Target intelligence / Profile preview

Family with sequence similarity 182 member A (FAM182A)

Target
FAM182A
Molecular classification
Other
01

Overview

Family with sequence similarity 182 member A (FAM182A) is a protein encoded by the *FAM182A* gene in humans[1]. It is also known by aliases including bB329D4.1 and C20orf91A. FAM182A belongs to a family of proteins characterized primarily by sequence similarity, and its precise molecular function, biological roles, disease associations, and potential as a therapeutic target remain uncharacterized in the scientific literature as of the current date.

Other names
bB329D4.1C20orf91AC20orf91

Beyond the preview

Go deeper on Family with sequence similarity 182 member A (FAM182A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Family with sequence similarity 182 member A (FAM182A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call